Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Controlled Study on Precision Irradiation of Regional Lymph Node for Clinical High-risk pN0 Breast Cancer

NCT05976412 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05976412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05976412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Controlled Study on Precision Irradiation of Regional Lymph Node for Clinical High-risk pN0 Breast Cancer
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 28, 2023
Completion date
May 31, 2031
Enrollment
1,355 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer